Report Description

The United States insulin pumps market is expected to grow at a significant rate during the forecast period. The increasing prevalence of diabetes in the United States requires efficient medical devices to examine the insulin level and take steps accordingly. The surge in the adoption of unhealthy eating habits, including consumption of junk food and other high sugar-containing edible items and beverages, is the major cause responsible for increases in the number of diabetic patients in the United States.

A strong economic position and well-developed healthcare infrastructure are expected to influence the market growth. The rise in disposable income among middle-class families is aiding to increase the healthcare expenditure capacity of patients, thereby boosting the demand for insulin pumps in the United States. Insulin pumps do not require the use of needles as conventional insulin measuring devices, which is a major factor attracting patients who are struggling with a daily injecting needle into the body. Insulin pumps stay on the human body and can transfer insulin easily and without causing any pain to the body if the need for additional insulin arises.

The United States insulin pumps market is segmented into type, insulin used, application, end-user, regional distribution, and company. Based on end-user, the market can be divided into hospitals & clinics, diagnostic centers, and home care. The hospitals & clinics segment is expected to dominate the market for the forecast period, 2023-2027. Huge patient in-flow into the hospital facilities and the occurrence of diabetes among the patients is expected to boost the growth of this segment. Favorable reimbursement policies along with increased government spending for the development of hospital facilities are expected to surge the demand for insulin pumps in hospitals & clinics.

The major players operating in the United States insulin pumps market are Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nipro Medical Corporation, among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Objective of the Study:

  • To analyze the historical growth of the market size of United States insulin pumps market from 2017 to 2020.
  • To estimate and forecast the market size of United States insulin pumps market from 2021 to 2027 and growth rate until 2027.
  • To classify and forecast United States insulin pumps market based on type, insulin used, application, end user, regional distribution, and company.
  • To identify dominant region or segment in the United States insulin pumps.
  • To identify drivers and challenges for United States insulin pumps market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States insulin pumps market.
  • To identify and analyze the profile of leading players operating in United States insulin pumps market.
  • To identify key sustainable strategies adopted by market players in United States insulin pumps market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States insulin pumps market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Insulin pumps manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to insulin pumps market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Type
  • Insulin Used
  • Application
  • End User

Regional scope

South-West, Mid-West, North-East

Key companies profiled

Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nipro Medical Corporation.

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, United States insulin pumps market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Insulin Pumps Market, By Type:

    • Traditional Insulin Pumps
    • Patch Pumps
  • United States Insulin Pumps Market, By Insulin Used:
    • Short Acting Insulin
    • Rapid Acting Insulin
  • United States Insulin Pumps Market, By Application:
    • Type 1 Diabetes
    • Type 2 Diabetes
  • United States Insulin Pumps Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Centers
    • Home Care
  • United States Insulin Pumps Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States insulin pumps market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

United States insulin pumps market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Insulin Pumps Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Insulin Pumps Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Traditional Insulin Pumps v/s Patch Pumps)

6.2.2.     By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin)

6.2.3.     By Application (Type 1 Diabetes v/s Type 2 Diabetes)

6.2.4.     By End User (Hospitals & Clinics, Diagnostic Centers, Home Care)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United States Traditional Insulin Pumps Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Insulin Used

7.2.2.     By Application

7.2.3.     By End User

8.    United States Patch Pumps Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Insulin Used

8.2.2.     By Application

8.2.3.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Import-Export Analysis

13.  United States Economic Profile

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.1.      Medtronic USA, Inc.

14.2.1.2.      Roche Diagnostics Corporation

14.2.1.3.      Becton, Dickinson and Company

14.2.1.4.      B. Braun Medical Inc.

14.2.1.5.      Abbott Laboratories, Inc.

14.2.1.6.      Insulet Corporation

14.2.1.7.      Tandem Diabetes Care, Inc.

14.2.1.8.      Nipro Medical Corporation

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Factors like increasing prevalence of diabetes, unhealthy eating habits among the population, advancing pharmaceutical sector are driving the growth of the United States insulin pumps market in the forecast years, 2023-2027.

down-arrow

Medtronic USA, Inc, Roche Diagnostics Corporation, Becton, Dickinson and Company, B. Braun Medical Inc., Abbott Laboratories, Inc., Insulet Corporation, among others are leading the United States insulin pumps market in the forecast period, 2023-2027.

down-arrow

The United States insulin pumps market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

profile

Sakshi Bajaal

Business Consultant
Press Release

Type 1 Diabetes Segment to Dominate the United States Insulin Pumps Market

Jul, 2021

Increasing demand for minimally invasive treatment and rise in chronic disorders is expected to drive the United States insulin pumps market for the forecast period.